Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study
Abstract Background Insertable cardiac monitors (ICMs) are increasingly used to evaluate the atrial fibrillation (AF) burden after catheter ablation of AF. BioMonitor III (BM3) is an ICM with a long sensing vector, which enhances sensing capabilities. The AF detection algorithm of the BM3 is based o...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | Annals of Noninvasive Electrocardiology |
Subjects: | |
Online Access: | https://doi.org/10.1111/anec.12960 |
_version_ | 1811216425822453760 |
---|---|
author | Amira Assaf Dominic A. M. J. Theuns Rafi Sakhi Rohit E. Bhagwandien Tamas Szili‐Torok Sing‐Chien Yap |
author_facet | Amira Assaf Dominic A. M. J. Theuns Rafi Sakhi Rohit E. Bhagwandien Tamas Szili‐Torok Sing‐Chien Yap |
author_sort | Amira Assaf |
collection | DOAJ |
description | Abstract Background Insertable cardiac monitors (ICMs) are increasingly used to evaluate the atrial fibrillation (AF) burden after catheter ablation of AF. BioMonitor III (BM3) is an ICM with a long sensing vector, which enhances sensing capabilities. The AF detection algorithm of the BM3 is based on R–R interval variability. Objective To evaluate the performance of the AF detection algorithm of BM3 in patients before and after catheter ablation of AF using simultaneous Holter recordings. Methods In this prospective study, we enrolled patients scheduled for catheter ablation of paroxysmal or persistent AF. After BM3 implantation, patients had a 4 days Holter registration before and 3 months after ablation. All true AF episodes ≥2 min on the Holter were annotated and matched with BM3 detected AF detections. Results Thirty‐one patients were enrolled (mean age 60 ± 8, 74% male, 68% paroxysmal AF). Fifty‐six Holter registrations were performed in 30 patients. Twelve patients demonstrated at least one true AF episode with a total AF duration of 570 h. The AF burden accuracy of BM3 before catheter ablation was 99.6%, with a duration sensitivity of 98.6% and a duration specificity of 99.9%. The AF burden accuracy of BM3 after catheter ablation was 99.8%, with a duration sensitivity of 90.2% and a duration specificity of 99.9%. Overall, the AF burden detected on the Holter and BM3 demonstrated a high Pearson correlation coefficient of 0.996. Conclusion BM3 accurately detects AF burden in patients before and after catheter ablation of AF. |
first_indexed | 2024-04-12T06:39:00Z |
format | Article |
id | doaj.art-4d2a1d33119747d68a33457a585aa779 |
institution | Directory Open Access Journal |
issn | 1082-720X 1542-474X |
language | English |
last_indexed | 2024-04-12T06:39:00Z |
publishDate | 2022-05-01 |
publisher | Wiley |
record_format | Article |
series | Annals of Noninvasive Electrocardiology |
spelling | doaj.art-4d2a1d33119747d68a33457a585aa7792022-12-22T03:43:47ZengWileyAnnals of Noninvasive Electrocardiology1082-720X1542-474X2022-05-01273n/an/a10.1111/anec.12960Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD studyAmira Assaf0Dominic A. M. J. Theuns1Rafi Sakhi2Rohit E. Bhagwandien3Tamas Szili‐Torok4Sing‐Chien Yap5Department of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsDepartment of Cardiology, Erasmus MC University Medical Center Rotterdam Rotterdam The NetherlandsAbstract Background Insertable cardiac monitors (ICMs) are increasingly used to evaluate the atrial fibrillation (AF) burden after catheter ablation of AF. BioMonitor III (BM3) is an ICM with a long sensing vector, which enhances sensing capabilities. The AF detection algorithm of the BM3 is based on R–R interval variability. Objective To evaluate the performance of the AF detection algorithm of BM3 in patients before and after catheter ablation of AF using simultaneous Holter recordings. Methods In this prospective study, we enrolled patients scheduled for catheter ablation of paroxysmal or persistent AF. After BM3 implantation, patients had a 4 days Holter registration before and 3 months after ablation. All true AF episodes ≥2 min on the Holter were annotated and matched with BM3 detected AF detections. Results Thirty‐one patients were enrolled (mean age 60 ± 8, 74% male, 68% paroxysmal AF). Fifty‐six Holter registrations were performed in 30 patients. Twelve patients demonstrated at least one true AF episode with a total AF duration of 570 h. The AF burden accuracy of BM3 before catheter ablation was 99.6%, with a duration sensitivity of 98.6% and a duration specificity of 99.9%. The AF burden accuracy of BM3 after catheter ablation was 99.8%, with a duration sensitivity of 90.2% and a duration specificity of 99.9%. Overall, the AF burden detected on the Holter and BM3 demonstrated a high Pearson correlation coefficient of 0.996. Conclusion BM3 accurately detects AF burden in patients before and after catheter ablation of AF.https://doi.org/10.1111/anec.12960atrial fibrillationBioMonitor IIIcatheter ablationimplantable loop recorderinsertable cardiac monitorpulmonary vein isolation |
spellingShingle | Amira Assaf Dominic A. M. J. Theuns Rafi Sakhi Rohit E. Bhagwandien Tamas Szili‐Torok Sing‐Chien Yap Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study Annals of Noninvasive Electrocardiology atrial fibrillation BioMonitor III catheter ablation implantable loop recorder insertable cardiac monitor pulmonary vein isolation |
title | Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study |
title_full | Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study |
title_fullStr | Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study |
title_full_unstemmed | Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study |
title_short | Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study |
title_sort | accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation results of the biovad study |
topic | atrial fibrillation BioMonitor III catheter ablation implantable loop recorder insertable cardiac monitor pulmonary vein isolation |
url | https://doi.org/10.1111/anec.12960 |
work_keys_str_mv | AT amiraassaf accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy AT dominicamjtheuns accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy AT rafisakhi accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy AT rohitebhagwandien accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy AT tamasszilitorok accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy AT singchienyap accuracyofatrialfibrillationdetectionbyaninsertablecardiacmonitorinpatientsundergoingcatheterablationresultsofthebiovadstudy |